Abstract:Background: The number of patients with cancer is increasing rapidly: in only one year, in 2020 19.3 million new cases were registered and as many as 10 million deaths occurred due to tumours worldwide. Shame and self-blame for developing cancer deteriorate patients' quality of life and correlate significantly with poor adaptation and physical health, consequently may be risk factors in the final negative outcome. It is proven that stigmatisation may cause torturing emotional symptoms like shame leading to depressive symptoms, which, in turn, may deteriorate the patient's capacity to cope and her well-being, thus growing the risk of mortality. For all the above, a high level of self-compassion may be a potential solution. Numerous studies have already proven that self-compassion may significantly decrease the level of shame, depression, frustration as well as the perception of being stigmatised while resulting in a measurably better quality of life. The purpose of the investigation was to point out the relationship between shame, stigmatisation, depression on the one hand, and selfcompassion on the other while providing support for the effectiveness of self-compassionbased interventions among female breast cancer patients. Methods: The present study is part of the fi rst phase of a translational research, in other words it is part of a basic research already carried out. This cross-sectional study collected data using online questionnaires based on self-reports with female breast cancer patients aged between 18 and 45, who had been diagnosed in the past two years and did not present with distant metastases (n=79, mean age: 39.05 years, SD= 7.37). To measure constructs standardised scales were applied including the Experience of Shame Scale (ESS), the Stigma Scale for Chronic Illnesses 8-item version (SSCI8), the Hospital Anxiety and Depression Scale (HADS) and the Self-Compassion Scale (SCS). The research hypotheses were tested by hierarchic regression, correlation, and mediation analyses. Results: Stigmatisation shows a positive and strong (r = 0.56, p < 0.01) relationship with physical shame while self-compassion has a negative and strong relationship with the same (r = 0.71, p < 0.01). Hierarchical regression revealed that self-compassion was the only predictive factor in female breast cancer patients regarding physical shame (β = - 0.09, p < 0.001) after controlling for age, marital status, exposure to operation, stigmatisation, and depression. According to mediation models a higher level of stigmatisation may result in a more expressed feeling of shame and depression through a lower level of self-compassion. We found a full mediation between shame and depression, which means that shame causes a higher level of depression entirely indirectly, through a decrease in self-compassion. Conclusions: The results of this work highlight the expected effectiveness of developing self-compassion in terms of alleviating shame, stigmatisation, and depression, thus contributing to a better quality of life among cancer patients. The main purpose of the translational research that was the basis of the present study was to develop a complex cognitive therapeutic programme that would, in a gap-filling way, offer oncological patients an effective psychological intervention supported by investigation. The results of the present study prove beyond doubt the rationale of the programme and involve the basic elaboration of a significant psycho-oncological practice.

Preliminary Evaluation of the Reliability and Validity of the Shame and Stigma Scale in Head and Neck Cancer.

Preliminary validation of the Chinese version of the Shame and Stigma Scale among patients with facial disfigurement from nasopharyngeal carcinoma

Shame and Stigma Over Long-Term Survival in Postoperative Cases of Head and Neck Cancer

Factors associated with shame and stigma among head and neck cancer patients: a cross-sectional study

Breast Cancer Stigma Scale: A Reliable and Valid Stigma Measure for Patients With Breast Cancer

Development and validation of the self-injury stigma scale

Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

Development and Psychometric Validation of the Breast Cancer Stigma Assessment Scale for Women with Breast Cancer and Its Survivors

Psychometric Properties of the Depression Stigma Scale (DSS) in Chinese Cancer Patients: a Cross-Sectional Study

Validation of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP)

Reliability and validity of a Chinese version of the Stigma Scale for Chronic Illness (SSCI) in patients with stroke.

Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort

[A study on self-compassion and stigmatisation in female patients with breast cancer]

Reliability and Validity Testing of the Patient and Observer Scar Assessment Scale in Evaluating Linear Scars after Breast Cancer Surgery

Validity and reliability of the Perceived Stress Scale among cancer survivors

Reliability and validity on the knowledge, attitude and behavior scale in cancer patients with PICC

Development and validation of the head and neck cancer psychosocial distress scale (HNCPDS) to identify patients at high risk for psychological problems : a multicenter study

Measuring internalized health-related stigma across health conditions: development and validation of the I-HEARTS Scale

Validation of a Chinese version of the short-form Cataldo lung cancer stigma scale

Preliminary Development of Mental Health Scale of Cosmetic Surgery Patients

Development, validity and reliability of the "Multiple sclerosis stigma scale"